Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC

Abroad (travel likely)RecruitingPHASE3

Conditions

Metastatic Prostate Cancer · Hormone Sensitive Prostate Cancer · Chemotherapy Effect

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Urology dpt, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Shangqian Wang, M.D.,PhD.) · wsq5501@126.com · 68303186
Contact: Principal Investigator (Lixin Hua, M.D.)

Study leads

Lixxin Hua
Principal Investigator
Urology Dpt, First Affiliated Hospital of Nanjing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer

IsraelRecruitingPHASE2, PHASE3

Los Angeles, United States · Palo Alto, United States

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumor · Melanoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · New Haven, United States

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Prostate Cancer · Prostate Cancer Metastatic Disease · Prostate Cancer Recurrent

Abroad (travel likely)Recruiting

Heerlen, Netherlands · Maastricht, Netherlands

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States